HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 262 filers reported holding HAEMONETICS CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,539,000 | -43.3% | 100,315 | -45.0% | 0.03% | -47.7% |
| Q1 2022 | $11,537,000 | +243.0% | 182,485 | +187.7% | 0.06% | +261.1% |
| Q4 2021 | $3,364,000 | -57.8% | 63,429 | -43.8% | 0.02% | -64.7% |
| Q3 2021 | $7,972,000 | -42.2% | 112,930 | -45.4% | 0.05% | -46.9% |
| Q2 2021 | $13,796,000 | +253.5% | 207,020 | +488.8% | 0.10% | +231.0% |
| Q1 2021 | $3,903,000 | -33.8% | 35,159 | -48.0% | 0.03% | -40.8% |
| Q3 2020 | $5,897,000 | -32.2% | 67,585 | -30.4% | 0.05% | -50.5% |
| Q2 2020 | $8,701,000 | +210.3% | 97,157 | +298.1% | 0.10% | +80.0% |
| Q4 2019 | $2,804,000 | -0.2% | 24,403 | +9.5% | 0.06% | +12.2% |
| Q3 2019 | $2,811,000 | +30.2% | 22,288 | -9.7% | 0.05% | -24.6% |
| Q1 2019 | $2,159,000 | -10.3% | 24,683 | -8.1% | 0.06% | 0.0% |
| Q2 2018 | $2,408,000 | +135.4% | 26,855 | +52.5% | 0.06% | +195.5% |
| Q4 2017 | $1,023,000 | – | 17,608 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
| Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
| Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
| CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
| Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
| COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
| Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
| EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |